Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
Hetero Healthcare Ltd
30 tablets
Emtricitabine and Tenofovir Alafenamide
Keep in cold place
Delivering To:
Overview
Tafero EM tablet is a combination of two anti-HIV medicines: Emtricitabine and Tenofovir Alafenamide. This medication is used for the treatment of HIV (human immunodeficiency virus) infection. It belongs to a class of medication known as nucleoside reverse transcriptase inhibitors (NRTIs). Tafero EM tablet boosts your immune system to fight against infection and prevents the virus from multiplying. It increases the CD4 cell (white blood cells that protect against infection) count in your blood. It is important to take this medicine as prescribed by your doctor. It is advised not to change your regular dosing schedule without taking suggestions from your doctor.
HIV
Manage human immunodeficiency virus 1 (HIV-1) infection (in adults and adolescents (aged 12 years and older) along with other medicines) Reduces the risk of getting HIV infection (in adult and adolescent men who have intercourse with men)
The following are the possible side effects that can occur during your treatment with Tafero-EM. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.
Trouble sleeping
Loss of strength
Fatigue
Sore throat
Swollen lymph nodes
Loss of appetite
Seizures
Cough
Unusual weakness
Tafero EM (Emtricitabine and Tenofovir Alafenamide) tablet is a combination of two antiretroviral medications. It helps to delay the production of HIV infection and improves the quality of life. This medication is not a permanent cure for HIV infection. It only prevents the multiplication of HIV (human immunodeficiency virus) infection in human cells. The recommended dose of Tafero EM medicine is decided by a doctor according to your previous medical condition and response to the treatment. Do not take this medicine in the wrong way as it may lead to some serious side effects. If you experience any signs and symptoms while receiving the Tafero-EM tablet, inform your doctor immediately.
Emtricitabine (Tafero EM), a synthetic nucleoside analog of cytidine, is phosphorylated by cellular enzymes to form emtricitabine 5'-triphosphate. Emtricitabine inhibits the activity of the HIV-1 reverse transcriptase (RT) by competing with the natural substrate deoxycytidine 5'-triphosphate and by being incorporated into nascent viral DNA, which results in chain termination.
Alcohol
unsafe
Do not consume alcohol while taking Tafero-EM.
Pregnancy
consult your doctor
Do not take Tafero-EM without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Do not take Tafero-EM if you're breastfeeding. Consultation of the doctor is advised.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of Tafero-EM.
Kidney
precaution
Do not take Tafero-EM without a doctor's consultation in case of kidney problems.
Liver
precaution
Share your medical history with the doctor in case of liver disease before taking Tafero-EM.
It is advisable not to miss a dose. If you miss a scheduled dose of Tafero EM tablets, contact your doctor immediately.
Tafero EM tablet is an antiviral medication that prevents the human immunodeficiency virus (HIV) from multiplying in your body. It also helps to delay the progression of HIV infection and improves the quality of life
This medication helps to boost your immune system to fight against infection and also increases the CD4 cell (white blood cells that protect against infection) count in your blood.
The effectiveness of Tafero EM Tablet in lowering women's risk of getting HIV has not been thoroughly studied. If you are a woman, speak with your doctor before using this medication.
Tafero-EM tablet is available in the strength of 200mg/25mg.
If you miss a scheduled dose of Tafero EM tablets, contact your doctor immediately.
Tafero EM Tablet does not appear to interact with grapefruit or grapefruit juice. But it's always a good idea to talk to your healthcare professional about any dietary issues or possible problems.
Follow your doctor’s advice about any restrictions on food and other activities.
Ali, S. H., Shah, M. H., Roy, S., Bharadwaj, H. R., Tan, J. K., Rao, M. S., Dalal, P. (2025). Efficacy and safety of tenofovir plus entecavir combination therapy versus tenofovir monotherapy in chronic hepatitis B virus patients with resistance or partial response to entecavir. Journal of Clinical and Experimental Hepatology, 15(4), 102541. PubMed+1PubMed+1
Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis. (2025). Frontiers in Pharmacology, 16, 1507117. PMC+1PubMed+1
Tenofovir alafenamide fumarate, tenofovir disoproxil fumarate, and entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta‑analysis. (2025). Journal of Viral Hepatitis & Hepatology.
Hetero Healthcare Ltd
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.